110 related articles for article (PubMed ID: 22153939)
21. Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides.
Chen X; Xu P; Xu Y; Liu L; Liu Y; Zhu D; Lei P
Bioorg Med Chem Lett; 2012 Dec; 22(24):7402-5. PubMed ID: 23122862
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN
Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548
[TBL] [Abstract][Full Text] [Related]
23. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections.
Lonks JR; Goldmann DA
Clin Infect Dis; 2005 Jun; 40(11):1657-64. PubMed ID: 15889365
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics.
Tanikawa T; Asaka T; Kashimura M; Misawa Y; Suzuki K; Sato M; Kameo K; Morimoto S; Nishida A
J Med Chem; 2001 Nov; 44(24):4027-30. PubMed ID: 11708904
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antibacterial activity of novel C12 vinyl ketolides.
Burger MT; Lin X; Chu DT; Hiebert C; Rico AC; Seid M; Carroll GL; Barker L; Huh K; Langhorne M; Shawar R; Kidney J; Young K; Anderson S; Desai MC; Plattner JJ
J Med Chem; 2006 Mar; 49(5):1730-43. PubMed ID: 16509588
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000).
Reinert RR; Rodloff AC; Halle E; Baer W; Beyreiss B; Seifert H; Wichelhaus TA; Maass M; Mehl M
Chemotherapy; 2004 Jun; 50(3):143-51. PubMed ID: 15272227
[TBL] [Abstract][Full Text] [Related]
27. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393
[TBL] [Abstract][Full Text] [Related]
28. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
[TBL] [Abstract][Full Text] [Related]
29. A simple method for deprotection of the N- and O-carbobenzoxy groups and N-methylation of the desosamine sugar moiety of ketolides. Application to the synthesis of ketolide analogues with various 9-iminoether moieties and their antibacterial activities.
Iwaki T; Nomura T; Narukawa Y; Uotani K
J Antibiot (Tokyo); 2005 Nov; 58(11):679-85. PubMed ID: 16466021
[TBL] [Abstract][Full Text] [Related]
30. [Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections].
Casellas JM; Visser M; Mac Dougall N; Coco B; Tomé G; Gliosca L;
Rev Esp Quimioter; 2001 Sep; 14(3):269-74. PubMed ID: 11753448
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with community-acquired respiratory tract infections: the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin study year 5 (2003-2004).
Blasi F; Farrell DJ; Dubreuil L
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):302-8. PubMed ID: 19135821
[TBL] [Abstract][Full Text] [Related]
32. Clinical management of respiratory tract infections in the community: experience with telithromycin.
Quintiliani R
Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
[TBL] [Abstract][Full Text] [Related]
33. Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.
Drago L; De Vecchi E; Nicola L; Legnani D; Gismondo MR
APMIS; 2005 Oct; 113(10):655-63. PubMed ID: 16309423
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antibacterial activity of 6-O-heteroarylcarbamoyl-11,12-lactoketolides.
Grant EB; Guiadeen D; Abbanat D; Foleno BD; Bush K; Macielag MJ
Bioorg Med Chem Lett; 2006 Apr; 16(7):1929-33. PubMed ID: 16446089
[TBL] [Abstract][Full Text] [Related]
35. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
Jenkins SG; Brown SD; Farrell DJ
Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.
Odenholt I; Löwdin E; Cars O
Antimicrob Agents Chemother; 2001 Jan; 45(1):23-9. PubMed ID: 11120939
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antibacterial activity of new 9-O-arylpropenyloxime ketolides.
Nam G; Kim YS; Choi KI
Bioorg Med Chem Lett; 2010 Apr; 20(8):2671-4. PubMed ID: 20338761
[TBL] [Abstract][Full Text] [Related]
38. Recent findings from multinational resistance surveys: are we 'PROTEKTed' from resistance?
Marchese A; Schito GC
Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S2-5. PubMed ID: 17307653
[TBL] [Abstract][Full Text] [Related]
39. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
Hoban DJ; Zhanel GG
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
Sunakawa K; Farrell DJ
Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
